Souhaitez-vous accéder aux communiqués récents ?

Alkeus Pharmaceuticals, Inc., today announced that results from its study of gildeuretinol in geographic atrophy were presented at AAO 2024.

- CLS-AX Phase 3 Ready Based on Positive Phase 2b Topline Data in Wet AMD - - Differentiated Profile for CLS-AX Targeting Flexible Dosing Similar to a Biologic with the Potential Extended Duration of...

Results from Study of Oral Gildeuretinol for Geographic Atrophy Secondary to Age-Related Macular Degeneration to be Presented as Late-Breaker During Retina Subspecialty Day Positive Data from TEASE...

ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...

Clearside Biomedical announced that multiple oral & poster presentations will be delivered at the American Academy of Ophthalmology (AAO) 2023 Annual Mtg.

EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023

Nextech will showcase transformative innovations to its ophthalmology industry-leading software at the AAO 2023 conference from Nov. 3-6.

Biotech startup to present 12 month data for novel Glaucoma treatment at AAO.

- Favorable Safety Profiles and Encouraging Efficacy Data Reported in Clinical Trials in the Suprachoroidal Space (SCS®) Across Multiple Therapeutic Areas using Clearside’s SCS Microinjector® - - SCS...

CHICAGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Leading vision enhancement platform, eSight, is holding demonstrations of its current medical device model, eSight 4, at the American Academy of...